Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?
作者信息
Agraz-Pamplona Irene, Montoro Bruno, Bury Roxana, Soler M Jose, Carro Clara Garcia, Solans Roser, Bolufer Monica, Cortes Josefina, Espinel Eugenia, Seron Daniel
出版信息
Semin Arthritis Rheum. 2020 Dec;50(6):e4. doi: 10.1016/j.semarthrit.2020.09.004. Epub 2020 Sep 22.
Abstract
摘要
相似文献
1
Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?接受免疫抑制药物治疗的肾小球疾病患者对重症SARS-CoV-2的抵抗力是否更强？
Semin Arthritis Rheum. 2020 Dec;50(6):e4. doi: 10.1016/j.semarthrit.2020.09.004. Epub 2020 Sep 22.
2
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19.针对 SARS-CoV-2 的神经入侵：用于抗击 COVID-19 的药物和抗体递送至新兴趋势。
ACS Chem Neurosci. 2021 Jul 21;12(14):2555-2557. doi: 10.1021/acschemneuro.1c00372. Epub 2021 Jul 6.
3
Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'.致编辑的信：回应《抗SARS-CoV-2和COVID-19的候选药物》一文
Pharmacol Res. 2021 Jan;163:105285. doi: 10.1016/j.phrs.2020.105285. Epub 2020 Nov 4.
4
Determination of inhibitor activity of drugs against the COVID-19.测定药物对 COVID-19 的抑制活性。
Bratisl Lek Listy. 2021;122(7):497-506. doi: 10.4149/BLL_2021_081.
5
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.柚皮素作为抗SARS-CoV-2的候选药物：TPC2基因变异在COVID-19中的作用。
Pharmacol Res. 2021 Feb;164:105402. doi: 10.1016/j.phrs.2020.105402. Epub 2020 Dec 24.
6
Therapeutic Agents Against COVID-19 with Clinical Evidence.抗 COVID-19 的治疗药物：临床证据。
Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951.
7
Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.肌毒性药物和免疫缺陷可能导致患有强直性肌营养不良的COVID-19患者预后不良。
Acta Neurol Belg. 2021 Jun;121(3):799-800. doi: 10.1007/s13760-020-01551-8. Epub 2020 Nov 23.
8
Update to living WHO guideline on drugs for covid-19.世界卫生组织关于新冠肺炎药物的现行指南更新。
BMJ. 2021 Jul 6;374:n1703. doi: 10.1136/bmj.n1703.
9
SDRIFE-like rash in COVID-19 patient: drug reaction or another cutaneous manifestation of SARS-CoV-2?新冠肺炎患者出现类似SDRIFE的皮疹：药物反应还是新型冠状病毒的另一种皮肤表现？
Int J Dermatol. 2021 Jul;60(7):884-885. doi: 10.1111/ijd.15537. Epub 2021 Mar 14.
10
The use of antimotility drugs in COVID-19 associated diarrhea.抗动力药物在新型冠状病毒肺炎相关腹泻中的应用
J Infect. 2021 Feb;82(2):e19. doi: 10.1016/j.jinf.2020.09.017. Epub 2020 Sep 19.
本文引用的文献
1
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.COVID-19 在接受靶向生物制剂和合成疾病修饰抗风湿药物治疗的成人和儿科风湿性疾病患者队列中的发病率。
Semin Arthritis Rheum. 2020 Aug;50(4):564-570. doi: 10.1016/j.semarthrit.2020.05.001. Epub 2020 May 16.
2
SARS-CoV-2 infection among patients with systemic autoimmune diseases.系统性自身免疫性疾病患者中的 SARS-CoV-2 感染。
Autoimmun Rev. 2020 Jul;19(7):102575. doi: 10.1016/j.autrev.2020.102575. Epub 2020 May 5.
3
Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients.肾移植患者中新型冠状病毒肺炎（COVID-19）疫情管理的建议
Nefrologia (Engl Ed). 2020 May-Jun;40(3):265-271. doi: 10.1016/j.nefro.2020.03.002. Epub 2020 Apr 3.
Zotero 插件